Compound ID | 203
Class: 3-hydrazinoquinoxaline-2-thiol
| Spectrum of activity: | Gram-negative |
| Details of activity: | Helicobacter pylori - Unknown mechanism of action |
| Institute where first reported: | Arietis Pharma, Boston, Massachusetts, USA |
| Year first mentioned: | 2014 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/781248 |
| Citations: |
|